SMTL ID : 5qcl.1

FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.11 Å

Oligo State

monomer

Ligands

1 x BUY: 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid(Non-covalent)

BUY.1: 27 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, C.45, Y.47, Y.134, L.137, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 Ligands: EDO.7 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:Y.134, A:I.141, A:A.183, A:K.185, A:T.206 Hydrogen bonds: A:R.26, A:L.28, A:K.185, A:G.186, A:D.187, A:S.188 Water bridges: A:I.141, A:I.141, A:G.209 pi-Stacking: A:H.44

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: K.160, R.161, R.177 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.161, A:R.177

10 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 5 residues within 4Å: Chain A: N.36, T.102, V.103, G.104, Y.105 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36, A:Y.105 EDO.4: 4 residues within 4Å: Chain A: Q.64, S.65, I.141, N.143 No protein-ligand interaction detected (PLIP) EDO.5: 2 residues within 4Å: Chain A: R.9, L.62 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.9 Water bridges: A:N.63 EDO.6: 9 residues within 4Å: Chain A: R.9, G.10, W.12, P.13, G.60, I.61, L.62, S.108, L.145 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:G.10, A:S.108 EDO.7: 6 residues within 4Å: Chain A: L.137, G.209, E.210, G.211 Ligands: BUY.1, EDO.8 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:G.209, A:G.211 EDO.8: 4 residues within 4Å: Chain A: E.89, G.209, E.210 Ligands: EDO.7 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.210 Water bridges: A:G.209, A:G.209 EDO.9: 4 residues within 4Å: Chain A: Q.25, I.67, K.68, E.69 No protein-ligand interaction detected (PLIP) EDO.10: 4 residues within 4Å: Chain A: H.169, M.171, I.172, N.223 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:H.169, A:N.223 Water bridges: A:V.153, A:N.155, A:E.226 EDO.11: 6 residues within 4Å: Chain A: S.90, G.91, Y.92, T.168, K.170, M.171 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.90, A:Y.92, A:T.168 Water bridges: A:Y.92 EDO.12: 4 residues within 4Å: Chain A: E.11, W.12, W.128, K.147 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.147 Water bridges: A:W.200

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pinto, D.J.P. et al., Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212). J. Med. Chem. (2017)

Release Date

2017-11-08

Peptides

Coagulation factor XI: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Coagulation factor XI

Related Entries With Identical Sequence